melanotan cancer study Targeting Peptidergic Systems for Melanoma Treatment Changes of melanocytic lesions inducedby
Description
Some research suggests that L-carnitine may reduce levels of C-reactive protein, a biomarker of inflammation
Sabatier N, Caquineau C, Douglas AJ, Leng G (2003b)
Add it to your cart today
The drug is not FDA-approved
